Stock & Company Details
India Globalization Capital Inc $IGC
Price:
N/A
N/A
116M
$25M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.79
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IGC technical indicators
Latest India Globalization Capital Inc (IGC) indicator readings as of 2026-10-29.
IGC's 14-day RSI is 21.9, in oversold territory. At $0.20 it is trading 29.0% below its 200-day moving average of $0.28, and below its 50-day average of $0.28. Price sits below the lower Bollinger Band ($0.22 to $0.30). ADX reads 23.3, sitting between trending and range-bound.
Overview
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
Finance Bot
Ask your questions
Start by typing a question below.
